Ensysce Biosciences Inc
Research Ensysce Biosciences Inc (ENSC) on Bullrun: market cap USD 5.92M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerENSC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.92M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 11.79M
- Free cash flow-USD 3.50M
Valuation Snapshot
latest market cap is USD 5.92M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 5.07M | -USD 10.18M | -USD 7.93M | n/a | -3.98 | USD 4.31M | USD 306.71K | USD 3.21M |
| FY2024 | USD 5.21M | -USD 7.99M | -USD 7.50M | n/a | -11.45 | USD 3.50M | USD 301.66K | USD 3.71M |
| FY2023 | USD 2.23M | -USD 10.63M | n/a | n/a | -70.4 | USD 1.12M | USD 854.70K | -USD 322.86K |
| FY2022 | USD 2.52M | -USD 24.21M | n/a | n/a | -139.42 | USD 3.15M | USD 2.67M | -USD 3.71M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.92M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 4.21M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 11.04M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.33M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 4.81M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 115.06M | n/a | n/a | n/a |
About Ensysce Biosciences Inc
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ensysce Biosciences Inc's market cap?
Ensysce Biosciences Inc's market capitalization is USD 5.92M.
What does Ensysce Biosciences Inc do?
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.